𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Immune responses to Puumala virus infection and the pathogenesis of nephropathia epidemica

✍ Scribed by Masanori Terajima; Olli Vapalahti; Heather L Van Epps; Antti Vaheri; Francis A Ennis

Book ID
108209842
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
276 KB
Volume
6
Category
Article
ISSN
1286-4579

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Analysis of Puumala hantavirus genome in
Analysis of Puumala hantavirus genome in patients with nephropathia epidemica and rodent carriers from the sites of infection
✍ Plyusnin, Alexander; Mustonen, Jukka; Asikainen, Kari; Plyusnina, Angelina; Niem πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 162 KB πŸ‘ 2 views

Reverse transcription-polymerase chain reaction (RT-PCR) followed by sequence and phylogenetic analyses were used to study specimens from nine Finnish nephropathia epidemica (NE) patients admitted to hospital during the epidemic in winter 1996-1997. Blood samples from six patients were found to be p

Comparison of the kinetics of puumala vi
Comparison of the kinetics of puumala virus specific IgM and IgG antibody responses in nephropathia epidemica as measured by a recombinant antigen-based enzyme-linked immunosorbent assay and an immunofluorescence test
✍ Fredrik Elgh; GΓΆran Wadell; Per Juto πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 512 KB

## Abstract Immunoglobulin M and G (IgM and IgG) responses were followed up to 6 months in patients with nephropathia epidemica (NE) by an enzyme‐linked immunosorbent assay (ELISA) using a recombinant Puumala virus (PUU) nucleocapsid protein as antigen and an immunofluorescence test (IF) using PUU

Viral determinants and host immune respo
Viral determinants and host immune responses in the pathogenesis of HBV infection
✍ Maria Rapicetta; Carlo Ferrari; Massimo Levrero πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 61 KB

## Abstract Hepatitis B virus (HBV) is a virus that infects about 350,000,000 people worldwide with a clinical spectrum of acute hepatitis, the healthy carrier state, cirrhosis and hepatocellular carcinoma (HCC). The outcome of HBV infection is the result of complicated viral‐host interactions. As